Return On Equity in % of Processa Pharmaceuticals, Inc. from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Processa Pharmaceuticals, Inc. quarterly and annual Return On Equity history and change rate from Q1 2014 to Q3 2025.
  • Processa Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -301%, a 54% decline year-over-year.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2024 was -233%, a 65% decline from 2023.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2023 was -141%, a 12% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2022 was -161%, a 300% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Processa Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -301% -106% -54% 01 Jul 2025 30 Sep 2025
Q2 2025 -342% -191% -127% 01 Apr 2025 30 Jun 2025
Q1 2025 -320% -189% -146% 01 Jan 2025 31 Mar 2025
Q4 2024 -233% -92% -65% 01 Oct 2024 31 Dec 2024
Q3 2024 -195% +61% +24% 01 Jul 2024 30 Sep 2024
Q2 2024 -151% +82% +35% 01 Apr 2024 30 Jun 2024
Q1 2024 -130% +75% +37% 01 Jan 2024 31 Mar 2024
Q4 2023 -141% +20% +12% 01 Oct 2023 31 Dec 2023
Q3 2023 -256% -174% -213% 01 Jul 2023 30 Sep 2023
Q2 2023 -233% -173% -284% 01 Apr 2023 30 Jun 2023
Q1 2023 -205% -158% -330% 01 Jan 2023 31 Mar 2023
Q4 2022 -161% -121% -300% 01 Oct 2022 31 Dec 2022
Q3 2022 -82% -17% -26% 01 Jul 2022 30 Sep 2022
Q2 2022 -61% +20% +25% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% +46% +49% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% +96% +70% 01 Oct 2021 31 Dec 2021
Q3 2021 -65% +15% +19% 01 Jul 2021 30 Sep 2021
Q2 2021 -81% -39% -91% 01 Apr 2021 30 Jun 2021
Q1 2021 -94% -51% -119% 01 Jan 2021 31 Mar 2021
Q4 2020 -136% -97% -248% 01 Oct 2020 31 Dec 2020
Q3 2020 -80% -44% -125% 01 Jul 2020 30 Sep 2020
Q2 2020 -43% -8.9% -26% 01 Apr 2020 30 Jun 2020
Q1 2020 -43% -9.3% -28% 01 Jan 2020 31 Mar 2020
Q4 2019 -39% -0.33% -0.85% 01 Oct 2019 31 Dec 2019
Q3 2019 -35% +16% +31% 01 Jul 2019 30 Sep 2019
Q2 2019 -34% +43% +56% 01 Apr 2019 30 Jun 2019
Q1 2019 -34% +179% +84% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% -201% -124% 01 Oct 2018 31 Dec 2018
Q3 2018 -51% -132% -164% 01 Jul 2018 30 Sep 2018
Q2 2018 -77% -144% -216% 01 Apr 2018 30 Jun 2018
Q1 2018 -212% -294% -359% 01 Jan 2018 31 Mar 2018
Q4 2017 162% +75% +86% 01 Oct 2017 31 Dec 2017
Q3 2017 81% -43% -35% 01 Jul 2017 30 Sep 2017
Q2 2017 67% -34% -34% 01 Apr 2017 30 Jun 2017
Q1 2017 82% -151% -65% 01 Jan 2017 31 Mar 2017
Q4 2016 87% -491% -85% 01 Oct 2016 31 Dec 2016
Q3 2016 124% -1638% -93% 01 Jul 2016 30 Sep 2016
Q2 2016 101% +4357% 01 Apr 2016 30 Jun 2016
Q1 2016 233% +866% 01 Jan 2016 31 Mar 2016
Q4 2015 578% +1238% 01 Oct 2015 31 Dec 2015
Q3 2015 1761% +2235% 01 Jul 2015 30 Sep 2015
Q2 2015 -4256% -3994% -1530% 01 Apr 2015 30 Jun 2015
Q1 2015 -634% -397% -168% 01 Jan 2015 31 Mar 2015
Q4 2014 -660% 01 Oct 2014 31 Dec 2014
Q3 2014 -473% 01 Jul 2014 30 Sep 2014
Q2 2014 -261% 01 Apr 2014 30 Jun 2014
Q1 2014 -236% 01 Jan 2014 31 Mar 2014

Processa Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -233% -92% -65% 01 Jan 2024 31 Dec 2024
2023 -141% +20% +12% 01 Jan 2023 31 Dec 2023
2022 -161% -121% -300% 01 Jan 2022 31 Dec 2022
2021 -40% +96% +70% 01 Jan 2021 31 Dec 2021
2020 -136% -97% -248% 01 Jan 2020 31 Dec 2020
2019 -39% -0.33% -0.85% 01 Jan 2019 31 Dec 2019
2018 -39% -201% -124% 01 Jan 2018 31 Dec 2018
2017 162% +75% +86% 01 Jan 2017 31 Dec 2017
2016 87% -491% -85% 01 Jan 2016 31 Dec 2016
2015 578% +1238% 01 Jan 2015 31 Dec 2015
2014 -660% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.